First Affiliated Hospital of Zhejiang University: all 260 studies

Page 1 of 3. Open to participants first (141), then studies with results posted, then the rest; newest registration first within each.

• Vitamin D Status and Its Influencing Factors in Zhejiang Province: A Multicenter Cross-Sectional StudyEnrolling by invitationNCT07866391
• 18F-S2P PET Imaging in the Evaluation of Large Artery AtherosclerosisNot yet recruitingNCT07815860Not applicable
• Belumosudil Versus Ruxolitinib for Steroid-Refractory or Breakthrough Hepatic cGVHDRecruitingNCT07794514Not applicable
• GMPA Versus PPI for Gastric Protection and aGVHD RiskRecruitingNCT07791849Not applicable
• SHR-A1811 Monotherapy or Sequential THPy as Neoadjuvant Therapy for Stage II-III HER2-Positive Breast CancerNot yet recruitingNCT07787338Phase 2
• Chidamide Maintenance to Prevent Relapse After Allogeneic Hematopoietic Stem Cell Transplantation in Acute T-Lymphoblastic Leukemia/LymphomaNot yet recruitingNCT07774377Phase 3
• Microbiome and Enteric Signatures in Sepsis-associated Hepatorenal InjuryRecruitingNCT07735182
• A Study on the Combination of Tongluo Huayu Formula in Treating RVO of Phlegm-Stasis Intertwinement Type: Based on the Mechanism of Systemic Metabolic Regulation Mediated by Gut MicrobiotaNot yet recruitingNCT07718503Not applicable
• Safety and Efficacy of Eculizumab in High-risk TA-TMARecruitingNCT07707687Phase 2
• Effect and Safety of Non-invasive Electrical Stimulation in Alzheimer's DiseaseEnrolling by invitationNCT07694921Not applicable
• Single-Dose vs. Divided-Dose G-CSF for Stem Cell Mobilization in Healthy Allogeneic DonorsRecruitingNCT07692841Phase 3
• Finerenone for Regression of Albuminuria in Type 2 Diabetes With Chronic Kidney DiseaseNot yet recruitingNCT07667517Phase 4
• Efficacy and Mechanism of IPSRT for Bipolar II DisorderNot yet recruitingNCT07654348Phase 2
• Comparing the Efficacy of the LDA, LHAA, and DA Regimens in Young Adults With Low-Risk Acute Myeloid Leukemia Eligible for Intensive ChemotherapyEnrolling by invitationNCT07651176Phase 2/3
• Comparing the Efficacy of LDA, LHAA, and LA Regimens in Young Adults With Intermediate- and High-Risk Acute Myeloid Leukemia Eligible for Intensive ChemotherapyEnrolling by invitationNCT07651163Phase 2/3
• Healthy Participants Randomized, Double-blind, Placebo-controlled, Phase ⅠRecruitingNCT07640438Phase 1
• A Clinical Study Evaluating the Safety, Tolerability, and Effect on HIV Reservoir of Ibalizumab Combined With Chidamide (a Histone Deacetylase Inhibitor) in People Living With HIVNot yet recruitingNCT07635992Phase 1
• Tafolecimab Combined With Sintilimab and SOX in the Treatment of pMMR/MSS Gastric CancerNot yet recruitingNCT07621562Phase 2
• Effects of Opioid Drugs on Sleep and Emotion in Patients With Moderate to Severe Cancer PainRecruitingNCT07616648
• Research on the Efficacy and Safety of Targeted Suprachiasmatic Nucleus Electrical Stimulation for Improving Metabolic Disorders in Patients With Stable Bipolar Disorder Comorbid With ObesityRecruitingNCT07589647Not applicable
• A Safety and Efficacy Trial of Chidamide Combined With NKG2D CAR-NK Cell Therapy for Reducing the HIV Viral ReservoirNot yet recruitingNCT07577986Phase 1/2
• PB-18 Probiotic for Mild to Moderate DepressionNot yet recruitingNCT07562516Not applicable
• A Randomized, Double-blind, Placebo-controlled, Prospective, Multi-center Trial Evaluating the Improvement of Nutritional Status and Sarcopenia With Silkworm Pupa Tablets in Patients With MalignanciesNot yet recruitingNCT07554807Phase 3
• Inulin-Spirulina Co-intervention for Insomnia DisorderNot yet recruitingNCT07537192Not applicable
• AI-assisted Decision-making of Reoperation for Postoperative Bleeding of Gastric CancerRecruitingNCT07525765
• 18F-FAPI PET/CT and MRI in Gastric CancerNot yet recruitingNCT07510867
• Characteristic Electroencephalogram of General AnesthesiaNot yet recruitingNCT07468162
• Comparison of Etamsylate Versus Placebo to Prevent Bleeding in HSCTRecruitingNCT07442513Phase 3
• CHRONO-MOBILIZE: Chronotherapy of G-CSF for CD34+ Mobilization in Healthy DonorsRecruitingNCT07423728Not applicable
• TMS for Improving Cognitive Function in Bipolar DisorderNot yet recruitingNCT07414147Not applicable
• Fludarabine Plus Melphalan Versus Addition of Venetoclax to Fludarabine/Melphalan Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in AML/MDS Patients Aged > 50 Years: a Multicenter, Randomized, Phase 3 TrialRecruitingNCT07396480Phase 3
• Remimazolam for Bronchoscopy in High-Risk PatientsRecruitingNCT07395596Phase 4
• The Efficacy and Safety of the Supraglottic Oxygenation Via Nasotracheal Intubation for Deep Sedation Fiberoptic BronchoscopyRecruitingNCT07389083Not applicable
• Neoadjuvant Therapy Combined With Trastuzumab Rezetecan and Toripalimab for HR+/HER2-low Breast Cancer (NEOTORCH-BREAST 08)RecruitingNCT07383818Phase 2
• Multicenter Study to Evaluate the Effectiveness and Safety of Flow-Diverting Stents for Distal Intracranial AneurysmsRecruitingNCT07376590
• 18F-FAPI PET in Cancers of Unknown Primary SiteNot yet recruitingNCT07372963
• Association of Different Tidal Volumes and Postoperative Pulmonary ComplicationsNot yet recruitingNCT07372378
• 18F-FAPI PET in Lung CancerNot yet recruitingNCT07370805
• Effects of Precise Education on Postoperative Discomfort Symptoms in Patients With Aortic Disease Undergoing Endovascular Intervention: a Single-center Randomized Controlled StudyNot yet recruitingNCT07362901
• Neoadjuvant Chemotherapy Combined With Sintilimab and Bevacizumab for TNBC (NEOTORCH-BREAST07)RecruitingNCT07351487Phase 2
• Safety and Efficacy of Iptacopan in Patients With High-Risk Transplantation-Associated Thrombotic MicroangiopathyRecruitingNCT07347990Not applicable
• Romiplostim N01 for Platelet Recovery After Haploidentical HSCTRecruitingNCT07321626Phase 1
• Stereotactic Aspiration of Brain Stem HematomaNot yet recruitingNCT07300501Not applicable
• First-Line Jaktinib for Acute Graft-Versus-Host Disease (aGVHD)RecruitingNCT07285889Phase 1/2
• Gilteritinib Plus VA Followed By Consolidation Chemotherapy in Newly Diagnosed FLT3-ITD+ AMLRecruitingNCT07259707Phase 2
• MR Microstructural Imaging for Prostate Cancer DiagnosisRecruitingNCT07249281
• A Study of A-CAR028 Treatment in Subjects With Relapsed or Refractory Acute Myeloid LeukemiaRecruitingNCT07198867Phase 1
• TEAVR With False Lumen Embolization for Aortic DissectionNot yet recruitingNCT07198295
• Ruxolitinib Plus Etanercept vs Ruxolitinib for Steroid-Refractory Severe Acute GVHDRecruitingNCT07184853Not applicable
• Venetoclax-Enhanced BUCY vs. Standard BUCY Conditioning in High-Risk AML and MDS Patients Undergoing Allo-HSCT (Ven-BUCY Study)RecruitingNCT07183878Not applicable
• New-Generation GMA Laryngeal Mask Airway Versus Conventional Inflatable Laryngeal Mask AirwayRecruitingNCT07177586Not applicable
• Alternating Regimen of VA and Low-dose CHA in the Treatment of Unfit Newly Diagnosed AMLRecruitingNCT07172204Phase 2
• Dragon Boat Race Versus Family Unsupervised Training to Improve the Physical Function and Quality of Life in Breast Cancer PatientsRecruitingNCT07162298Phase 2
• Homoharringtonine, BCL-2 Inhibitor, Rituximab, and Prednisone in Relapsed/Refractory Diffuse Large B-Cell LymphomaNot yet recruitingNCT07159906Phase 1/2
• An Observational Study on Lecanemab Treatment for Early Alzheimer's DiseaseRecruitingNCT07153848
• 18F-Pentixafor PET in Hematologic MalignanciesRecruitingNCT07122674
• A Prospective Study of Discomfort Symptoms in Patients With Aortic Disease After Endovascular InterventionNot yet recruitingNCT07114185
• Effectiveness and Safety of Blinatumomab and Donor Lymphocyte Infusion in Maintenance Therapy After Allogeneic Hematopoietic Stem Cell Transplantation for High-risk Ph Negative B Cell Acute Lymphoblastic LeukemiaRecruitingNCT07105579Phase 2
• 18F-AlF-NOTA-Octreotide PET in Neuroendocrine NeoplasmsNot yet recruitingNCT07102056
• Individualized Location-based rTMS for Migraine Treatment: A Multicenter Clinical StudyNot yet recruitingNCT07086274Not applicable
• A Prospective Study of ¹⁸F-DFA PET Imaging for the Assessment of Liver InjuryRecruitingNCT07050550
• Construction and Clinical Application of the Immune Map of Pancreatic Cancer EvolutionRecruitingNCT07034339
• Sequential Anti-Angiogenic Therapy After Immunotherapy in Advanced Biliary Tract CancerRecruitingNCT07025174Phase 2
• Efficacy and Safety Assessment of Temporal Interference Stimulation to Improve Bipolar DepressionRecruitingNCT07021508Not applicable
• Blinatumomab Intensification for MRD-Negative Acute B-Cell Lymphoblastic Leukemia Before Allogeneic Hematopoietic Stem Cell TransplantationRecruitingNCT07003737Not applicable
• Neoadjuvant Chemotherapy in Combination With Toripalimab for HR+/HER2- Breast Cancer : a Randomized, Open-label, Parallel-controlled, Multi-center Phase III Study (NEOTORCH-BREAST04)RecruitingNCT06977893Phase 3
• Comparison of Different Acceleration Modes of Transcranial Magnetic StimulationNot yet recruitingNCT06881030Not applicable
• Neoadjuvant Chemotherapy in Combination With Anlotinib and Benmelstobart for HR+/HER2- Breast Cancer (NEOTORCH-BREAST03)RecruitingNCT06874933Phase 2
• Transperineal Irreversible Electroporation for Benign Prostatic HyperplasiaRecruitingNCT06867315Not applicable
• SCRT Combined With Chemotherapy and Iparomlimab and Tuvonralimab in MSS or pMMR Patients With Locally Advanced Rectal CancerRecruitingNCT06864013Phase 2
• Effectiveness and Safety of InO±DLI for Relapsed B-ALL/LBL After Allo-HSCTNot yet recruitingNCT06861348Phase 2
• 18F-mFBG PET Imaging in the Evaluation of NeuroblastomaRecruitingNCT06852807
• SCRT-CAPEOX-Serplulimab for MSS/pMMR Rectal Cancer With OligometastasesRecruitingNCT06850103Phase 2
• Neoadjuvant Chemotherapy Plus Pyrotinib and Trastuzumab for HER2-positive Breast Cancer (NEOTORCH-BREAST05)RecruitingNCT06832904Phase 2
• The Efficacy and Safety of Task-state-based Temporal Interference Stimulation (TI) in the Treatment of Patients With DepressionNot yet recruitingNCT06826469Not applicable
• 18F-mFBG PET Imaging in the Evaluation of PheochromocytomaRecruitingNCT06813742
• Clinical Study on the Safety and Efficacy of Autologous CD84 Chimeric Antigen Receptor T-Cell Therapy for Adult Relapsed/Refractory Acute Myeloid Leukemia.Not yet recruitingNCT06786299Early Phase 1
• Inaticabtagene Autoleucel (Inati-cel; CNCT19) Treatment for Newly Diagnosed B-cell ALL Patients in CR1Not yet recruitingNCT06777264Phase 2
• Venetoclax Combined With Olverembatinib and Predinisone in Treating Ph+ B-ALLRecruitingNCT06754267Phase 2
• Universal CNK-UT Therapy for Refractory aGVHDRecruitingNCT06750133Phase 1
• Blinatumomab Plus Reduced-dose Chemotherapy in Treating B-ALLRecruitingNCT06742515Phase 2
• VHAG in Treating R/R T-ALL/LBLRecruitingNCT06742463Phase 2
• Remimazolam Besylate in Sedation of Postcardioperative PatientsRecruitingNCT06716840Not applicable
• Radiotherapy Followed by Chemotherapy Combined With Toripalimab in Local Advanced HR-positive,HER2-negative BC.RecruitingNCT06705127Phase 2
• Neoadjuvant Chemotherapy Combined With Toripalimab for TNBC (NEOTORCH-BREAST02)RecruitingNCT06682195Phase 2
• Mitoxantrone Hydrochloride Liposome, Standard-dose of Cytarabine and Venetoclax in the Treatment of R/R AMLRecruitingNCT06621212Phase 2
• Mitoxantrone Hydrochloride Liposome in Combination With Cytarabine and Venetoclax Regimen in Newly Diagnosed Elderly AMLRecruitingNCT06621199Phase 2
• Prediction of Stroke Risk in Patients with Atrial Fibrillation Based on Chest CT ImagesNot yet recruitingNCT06611995
• Neoadjuvant Chemotherapy in Combination With Toripalimab for HR+/HER2- Breast Cancer (NEOTORCH-BREAST01)RecruitingNCT06611813Phase 2
• Blinatumomab Plus Venetoclax Sequenced With Inotuzumab Ozogamicin in Treating B-ALLRecruitingNCT06554626Phase 2
• Study on the Correlation Between Fat Soluble Vitamins and Non-alcoholic Fatty Liver DiseaseRecruitingNCT06512701
• Optimize Study - Orelabrutinib Combined With BR/G in Untreated Marginal Zone Lymphoma (MZL)RecruitingNCT06504940Phase 2
• The Peripheral Blood Multi-Omics Study on Sleep LossRecruitingNCT06492109Not applicable
• Efficacy and Safety of Methylene Blue in the Treatment of Severe Septic ShockRecruitingNCT06481410Not applicable
• Primary Multiple Myeloma Who Achieved MRD Negativity After Induction Therapy, ASCT or NotRecruitingNCT06463717
• Position Intervention to Reduce Hypoxemia in Sedation PatientsNot yet recruitingNCT06459167Not applicable
• Efficacy and Safety of Modified Si Jun Zi Tang in Perioperative NSCLC TreatmentRecruitingNCT06445881Phase 2
• Mitoxantrone Hydrochloride Liposome Injection, Cytarabine Combined With Venetoclax in the Treatment of R/R AMLRecruitingNCT06434662Phase 2
• Micro-movements in Patients With Prolonged Disorders of ConsciousnessRecruitingNCT06406413
• Electroencephalogram Characteristics of Surgical Anesthetized Patients and Postoperative DiliriumEnrolling by invitationNCT06394778

← First Affiliated Hospital of Zhejiang University overview and focus areas